Skip to content

Alkermes ALKS PEG ratio

PEG ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
0.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
Royalty Pharma logo
Royalty PharmaRPRX
0.3×
Viatris logo
ViatrisVTRS
0.1×
Biogen logo
BiogenBIIB
0.4×

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Calculated from Alkermes’s reported figures.

Based on the most recent quarter.

The official record: Alkermes’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's PEG ratio?
Alkermes (ALKS) reported PEG ratio of 8.9× in Q3 2025.
How has Alkermes's PEG ratio changed year-over-year?
Alkermes's PEG ratio increased by 3452.1% year-over-year, from 0.3× to 8.9×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.